These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3591254)

  • 1. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
    Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
    Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaesthesia in malignant hyperthermia-susceptible patients without dantrolene prophylaxis: a report of 30 cases.
    Hackl W; Mauritz W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Scand; 1990 Oct; 34(7):534-7. PubMed ID: 2244439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
    Jantzen JP; Erdmann K; Kleemann PP
    Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
    Schuh FT; Maier C
    Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
    Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
    Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia.
    Fairhurst AS; Hamamoto V; Macri J
    Anesthesiology; 1980 Sep; 53(3):199-204. PubMed ID: 7425333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
    Halsall PJ; Ellis FR
    Br J Anaesth; 1979 Aug; 51(8):753-6. PubMed ID: 497072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
    Ruhland G; Hinkle AJ
    Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia: a possible new variant.
    Lee DS; Adams JP; Zimmerman JE
    Can Anaesth Soc J; 1985 May; 32(3 Pt 1):268-71. PubMed ID: 4005678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse.
    Valverde A; Boyd CJ; Dyson DH; Pascoe PJ
    J Am Vet Med Assoc; 1990 Oct; 197(8):1051-3. PubMed ID: 2243040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
    Abballe C; Primieri P; De Cosmo G
    Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia revisited.
    Eichhorn JH
    Plast Reconstr Surg; 1988 Nov; 82(5):883-5. PubMed ID: 3271388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.